Tag
A discussion-style post asking how AI is currently accelerating medical research and development, and whether its impact in medicine will eventually match what it has achieved in programming and mathematics, or if breakthroughs beyond LLMs like world models and robotics are needed. The author is personally motivated to follow progress in the field due to their own health issues.
A new review in the New England Journal of Medicine highlights that polygenic risk scores for various diseases cost only $20 and are informative for high-risk individuals across ancestries, underscoring the underutilized value of genomics in medical practice.
The post highlights AI's achievements in medicine, such as enabling paralyzed individuals to speak and walk through brain implants and spinal interfaces.
Dr. Matthew Zirwas retracts his earlier dismissal of the Midjourney ultrasound scanner, acknowledging that if it is high-resolution, harmless, inexpensive, and convenient, frequent screening could overcome historical pitfalls of unnecessary invasive procedures, though he emphasizes that data is needed to confirm benefit.
A study from King's College London reveals that hospitals and universities are conducting late-stage clinical trials for repurposing generic drugs at less than 10% of pharmaceutical companies' costs, offering affordable treatments for conditions like blindness, cancer prevention, and Covid.